Aldosterone is a key regulator of electrolyte and water homeostasis and plays a central role in blood pressure regulation. Hormonal changes during pregnancy, among them increased progesterone and aldosterone production, lead to the required plasma volume expansion of the maternal body as an accommodation mechanism for fetus growth. This review discusses the regulation of aldosterone production by aldosterone synthase (CYP11B2); the impact on aldosterone secretion due to the presence of a chimeric gene originating from a crossover between CYP11B1 and CYP11B2 in glucocorticoid remediable aldosteronism (GRA) — the inherited form of hypertension; enhanced aldosterone production in aldosterone-producing adenoma (APA); and idiopathic hyperaldosteronism (IHA). Features of hyperaldosteronism are also found in patients with apparent mineralocorticoid excess (AME), in which glucocorticoids exacerbate activation of the mineralocorticoid receptor (MR) because of a defect in the 11β-hydroxysteroid dehydrogenase type 2 enzyme. Regulation of aldosterone production and tissue-specific activation of the mineralocorticoid receptor are prerequisites for optimal control of body fluids and blood pressure during pregnancy and contribute largely to the wellbeing of the mother-to-be.
Albiston, A.L., Smith, R.E., Obeyesekere, V.R. and Krozowski, Z.S. (1995) Cloning of the 11β-HSD type II enzyme from human kidney, Endocr Res21: 399-409.
2.
Assali, N.S. and Westersten, A. (1961) Regional flow-pressure relationship in response to angiotensin in the intact dog and sheep, Circ Res9: 189-193.
3.
Brand, E., Chatelain, N., Mulatero, P., Féry, I., Curnow, K., Jeunemaitre, X. et al. (1998) Structural analysis and evaluation of the aldosterone synthase gene in hypertension, Hypertension32: 198-204.
4.
Brown, M.A., Thou, S.T. and Whitworth, J.A. (1995) Stimulation of aldosterone by ACTH in normal and hypertensive pregnancy, Am J Hypertens8: 260-267.
5.
Chapman, A.B., Abraham, W.T., Zamudio, S., Coffin, C., Merouani, A., Young, D. et al. (1998) Temporal relationships between hormonal and hemodynamic changes in early human pregnancy, Kidney Int54: 2056-2063.
Connell, J.M. and Davies, E. (2005) The new biology of aldosterone, J Endocrinol186: 1-20.
8.
Dave-Sharma, S., Wilson, R.C., Harbison, M.D., Newfield, R., Azar, M.R., Krozowski, Z.S. et al. (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess, J Clin Endocrinol Metab83: 2244-2254.
9.
Davies, E., Holloway, C.D., Ingram, M.C., Inglis, G.C., Friel, E.C. et al. (1999) Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2, Hypertension33: 703-707.
Funder, J.W. (2007) Why are mineralocorticoid receptors so nonselective ? Curr Hypertens Rep9: 112-116.
12.
Gallery, E.D. and Brown, M.A. (1987) Control of sodium excretion in human pregnancy , Am J Kidney Dis9: 290-295.
13.
Gallery, E.D., Hunyor, S.N. and Gyrory, A.Z. (1979) Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy, J Med48: 593-602.
14.
Gant, N.F., Daley, G.L., Chand, S., Whalley, P.J. and MacDonald, P.C. (1973) A study of angiotensin II pressor response throughout primigravid pregnancy, J Clin Invest52: 2682-2689.
15.
Geller, D.S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A. et al. (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy, Science289: 119-123.
16.
Goland, R.S., Wardlaw, S.L., Stark, R.I., Brown Jr, L.S. and Frantz, A.G. (1986) High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy, J Clin Endocrinol Metab63: 1199-1203.
17.
Jeunemaitre, X., Chatellier, G., Kreft-Jais, C., Charru, A., DeVries, C., Plouin, P.F. et al. (1987) Efficacy and tolerance of spironolactone in essential hypertension, Am J Cardiol60: 820-825.
18.
Kalenga, M.K., De Gasparo, M., Thomas, K. and De Hertogh, R. (1996) Down-regulation of angiotensin AT1 receptor by progesterone in human placenta, J Clin Endocrinol Metab81: 998-1002.
19.
Kreze Jr, A., Kothaj, P., Dobáková, M. and Rohon, S. (1999) Primary aldosteronism caused by aldosterone-producing adenoma in pregnancy - complicated by EPH gestosis, Wien Klin Wochenschr111: 855-857.
20.
Krozowski, Z.S., Stewart, P.M., Obeyesekere, V.R., Li, K. and Ferrari, P. (1997) Mutations in the 11β-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth, Clin Exp Hypertens19: 519-529.
21.
Lee, I.H., Campbell, C.R., Cook, D.I. and Dinudom, A. (2008) Regulation of epithelial Na+ channels by aldosterone: role of Sgk1, Clin Exp Pharmacol Physiol35: 235-241.
22.
LeHoux, J.G., Dupuis, G. and Lefebvre, A. (2000) Regulation of CYP11B2 gene expression by protein kinase C, Endocr Res26: 1027-1031.
23.
Longo, L.D. (1983) Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control, Am J Physiol245: R720-729.
24.
Matsubara, M. (2000) Genetic determination of human essential hypertension , Tohoku J Exp Med192: 19-33.
25.
Miyahara, K., Kawamoto, T., Mitsuuchi, Y., Toda, K., Imura, H., Gordon, R.D. et al. (1992) The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity, Biochem Biophys Res Commun189: 885-891.
26.
Miyamori, I., Inaba, S., Hatakeyama, H., Taniguchi, N. and Takeda, Y. (2000) Idiopathic hyperaldosteronism: analysis of aldosterone synthase gene, Biomed Pharmacother54: 77s-79s.
27.
Mulatero, P., Schiavone, D., Fallo, F., Rabbia, F., Pilon, C., Chiandussi, L. et al. (2001) CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism, Hypertension35: 694-698.
28.
Mulatero, P., Veglio, F., Pilon, C., Rabbia, F., Zocchi, C., Limone, P. et al. (1998) Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene, J Clin Endocrinol Metab83: 2573-2575.
29.
Murakami, T., Watanabe Ogura, E., Tanaka, Y. and Yamamoto, M. (2000) High blood pressure lowered by pregnancy, Lancet356: 1980.
30.
Myles, K. and Funder, J.W. (1996) Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies, Am J Physiol270: E601-607.
31.
Neerhof, M.G., Shlossman, P.A., Poll, D.S., Ludomirsky, A. and Weiner, S. (1991) Idiopathic aldosteronism in pregnancy, Obstet Gynecol78: 489-491.
32.
New, M.I., Levine, L.S., Biglieri, E.G., Pareira, J. and Ulick, S. (1977) Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension, J Clin Endocrinol Metab44: 924-933.
33.
Oda, N., Takeda, Y., Zhu, A., Usukura, M., Yoneda, T., Takata, H. et al. (2006) Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism, Hypertens Res29: 9-14.
34.
Pirani, B.B., Campbell, D.M. and MacGillivray, I. (1973) Plasma volume in normal first pregnancy, J Obstet Gynaecol Br Commonw80: 884-887.
35.
Quinkler, M., Johanssen, S., Grossmann, C., Baöhr, V., Muller, M., Oelkers, W. et al. (1999) Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites, Clin Endocrinol Metab84: 4165-4171.
36.
Quinkler, M., Meyer, B., Oelkers, W. and Diederich, S. (2003) Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo, J Clin Endocrinol Metab88: 3767-3772.
37.
Rafestin-Oblin, M.E., Souque, A., Bocchi, B., Pinon, G., Fagart, J. and Vandewalle, A. (2003) The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related, Endocrinology144: 528-533.
38.
Roberts, J.M. and Cooper, D.W. (2001) Pathogenesis and genetics of pre-eclampsia, Lancet357: 53-56.
39.
Rossi, G.P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C. et al. (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients, J Am Coll Cardiol48: 2293-2300.
40.
Schoof, E., Girstl, M., Frobenius, W., Kirschbaum, M., Repp, R., Knerr, I. et al. (2001) Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation, Eur J Endocrinol145: 187-192.
41.
Shojaati, K., Causevic, M., Kadereit, B., Dick, B., Imobersteg, J., Schneider, H. et al. (2004) Evidence for compromised aldosterone synthase enzyme activity in preeclampsia, Kidney Int66: 2322-2328.
42.
So, A., Duffy, D.L., Gordon, R.D., Jeske, Y.W., Lin-Su, K., New, M.I. et al. (2005) Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity, Hypertens23: 1477-1484.
43.
Solomon, C.G., Thiet, M., Moore Jr, F. and Seely, E.W. (1996) Primary hyperaldosteronism in pregnancy, J Reprod Med41: 255-258.
44.
Stowasser, M., Gordon, R.D., Tunny, T.J., Klemm, S.A., Finn, W.L. and Krek, A.L. (1992) Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism, Clin Exp Pharmacol Physiol19: 319.
45.
Stowasser, M., Sharman, J., Leano, R., Gordon, R.D., Ward, G., Cowley, D. et al. (2005) Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I, J Clin Endocrinol Metab90: 5070-5076.
46.
Takeda, Y., Miyamori, I., Yoneda, T., Hatakeyama, H., Inaba, S., Furukawa, K. et al. (1996) Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin, J Clin Endocrinol Metab81: 2797-2800.
47.
Tamaki, S., Iwai, N., Tsujita, Y. and Kinoshita, M. (1999) Genetic polymorphism of CYP11B2 gene and hypertension in Japanese, Hypertension33: 266-270.
48.
Weissgerber, T.L. and Wolfe, L.A. (2006) Physiological adaptation in early human pregnancy: adaptation to balance maternal-fetal demands, Appl Physiol Nutr Metab1: 1-11.
49.
Wieacker, P., Alexopoulos, A., DeGregorio, G. and Breckwoldt, M. (1989) Pregnancy in Addison's disease, Dtsch Med Wochenschr114: 1117-1120.
Yu, H., Lin, S., Zhang, Y. and Liu, G. (2008) Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors, J Hypertens26: 251-256.
